Cite
APA Citation
Dodick, D. W., Gottschalk, C., Cady, R., Hirman, J., Smith, J., & Snapinn, S. (2020). eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache, 60(10), 2220–2231. http://access.bl.uk/ark:/81055/vdc_100114921512.0x000063